Fulgent Genetics Inc (FLGT)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $688.98M
Last updated: Nov 17, 2026 at 11:06 AM ET
Fulgent Genetics Inc (FLGT) Competitors
The companies most similar to Fulgent Genetics are Myriad Genetics (MYGN), NeoGenomics (NEO) and Castle Biosciences (CSTL). By market cap, Fulgent Genetics ranks 10th of the 13 companies on this page; Illumina (ILMN) is the largest at $31.30B. The median P/E of the 5 companies with a P/E is 37.7x.
Peer Comparison
FLGT's ROIC of -12.1% is below the peer median of -4.1%, and its revenue growth of 7.5% is below the median of 9.1%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Fulgent Genetics (FLGT) | $688.98M | N/A | 2.0x | -27.5% | -12.1% | 7.5% | 0.00% |
| Myriad Genetics Inc (MYGN) | $542.92M | N/A | 0.7x | -16.1% | -29.5% | -1.5% | 0.00% |
| NeoGenomics Inc (NEO) | $2.07B | 228.9x | 2.6x | -4.1% | -2.5% | 11.4% | 0.00% |
| Castle Biosciences Inc (CSTL) | $1.04B | N/A | 2.7x | -6.1% | -5.4% | 23.9% | 0.00% |
| Personalis Inc (PSNL) | $1.70B | N/A | 20.9x | -147.7% | N/A | 76.6% | 0.00% |
| Veracyte Inc (VCYT) | $1.96B | 13.3x | 3.3x | 21.8% | 8.2% | 15.1% | 0.00% |
| Opko Health Inc (OPK) | $1.25B | N/A | 2.4x | -22.6% | -6.2% | 15.9% | 0.00% |
| CareDx Inc (CDNA) | $4.09B | 48.2x | 6.4x | 25.9% | N/A | 39.3% | 0.00% |
| GRAIL, LLC (GRAL) | $5.21B | N/A | 29.6x | -243.8% | N/A | 3.7% | 0.00% |
| QuidelOrtho Corp (QDEL) | $736.90M | 11.9x | 0.3x | -14.2% | -2.9% | -11.6% | 0.00% |
| Illumina Inc (ILMN) | $31.30B | 37.7x | 6.6x | 19.7% | 19.1% | 4.2% | 0.00% |
| Exagen Inc (XGN) | $105.37M | N/A | 1.3x | -25.1% | -40.4% | 6.8% | 0.00% |
| Fulcrum Therapeutics Inc (FULC) | $287.96M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Peer median | $1.48B | 37.7x | 2.7x | -10.1% | -4.1% | 9.1% | 0.00% |
Similar Companies
These are the 12 companies most similar to Fulgent Genetics, ranked by how closely their business, size, sector and industry match. The largest group, 10 of the 12, is in Diagnostics & Research; the other 2 span 2 industries.
| Company | About | Peers |
|---|---|---|
| Myriad Genetics Inc (MYGN)Diagnostics & Research | Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized... | MYGN competitors |
| NeoGenomics Inc (NEO)Diagnostics & Research | NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. | NEO competitors |
| Castle Biosciences Inc (CSTL)Diagnostics & Research | Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests... | CSTL competitors |
| Personalis Inc (PSNL)Diagnostics & Research | Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California. | PSNL competitors |
| Veracyte Inc (VCYT)Diagnostics & Research | Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California. | VCYT competitors |
| Opko Health Inc (OPK)Diagnostics & Research | OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico... | OPK competitors |
| CareDx Inc (CDNA)Diagnostics & Research | CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. | CDNA competitors |
| GRAIL, LLC (GRAL)Diagnostics & Research | GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics... | GRAL competitors |
| QuidelOrtho Corp (QDEL)Medical Devices | Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health... | QDEL competitors |
| Illumina Inc (ILMN)Diagnostics & Research | Illumina, Inc. is an American company. | ILMN competitors |
| Exagen Inc (XGN)Diagnostics & Research | Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name... | XGN competitors |
| Fulcrum Therapeutics Inc (FULC)Biotechnology | Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined... | FULC competitors |
Frequently Asked Questions About FLGT
Who are Fulgent Genetics' main competitors?
The companies most similar to Fulgent Genetics include Myriad Genetics (MYGN), NeoGenomics (NEO), Castle Biosciences (CSTL), Personalis (PSNL) and Veracyte (VCYT), listed from the closest match.
Who is Fulgent Genetics' biggest competitor?
Illumina (ILMN) is the largest of the similar companies at $31.30B; Myriad Genetics (MYGN) is the closest match by business profile, size, sector and industry.
How does FLGT stock compare with its competitors?
FLGT's P/S is 2.0x against a peer median of 2.7x; its net margin is -27.5% against a peer median of -10.1%.
Which of Fulgent Genetics' competitors pays a higher dividend?
Fulgent Genetics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Fulgent Genetics bigger than its competitors?
No. Fulgent Genetics is 10th by market cap among the 13 companies on this page; the largest is Illumina (ILMN) at $31.30B.
FLGT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts